Autopsy report · NCT01826838

Study of Dasatinib, Androgen Deprivation Therapy and Radiation

“Lack of patients”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Brown University

Sponsor type

University, hospital or other

Conditions

Prostate Cancer

Interventions

Dasatinib

Participants

0

Trials that died the same way

• Safety Study of Using Symlin Alongside Insulin in a Multiple Injection Port
  “Lack of patient population” (87% match in meaning)
• Endothelial Protection in Convalescent COVID-19 Patients
  “Lack of the eligible patients” (85% match in meaning)
• Serial Evaluation of Drug-Eluting Stents Using OCT (STRUT-OCT)
  “Lack of eligible patients” (84% match in meaning)
• POLA+BR for Relapsed or Refractory DLBCL
  “Lack of sufficient patient population” (84% match in meaning)
• Ridge Preservation Comparing Simultaneous vs. Delayed Grafting
  “Not enough patients available” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.